News

The analysis found that among newborns (0–2 months), RSV hospitalizations fell 52 percent in RSV-NET and 45 percent in NVSN compared with the rates from the 2018–2020 period.
Due to a law enacted in 2023, Medicare now covers the RSV vaccine for older adults under Part D, which typically covers prescription drugs. This means you shouldn’t incur any out-of-pocket costs.
RSV vaccines greatly reduced the likelihood of RSV-associated hospitalizations, critical illness (including death), and ED visits compared to not receiving an RSV vaccine.
For adults, RSV vaccines show continued protection even two years after immunization. Based on this, the CDC recommends only one dose of the RSV vaccine for seniors right now, but this may change ...
RSV vaccines effective, but more people need to get them Date: October 28, 2024 Source: University of Rochester Medical Center Summary: Doctors detail what we learned after the first season ...
In infants, we know that the vaccine given to those who are pregnant protects babies for their first 6 months of life – when they are most at risk for the virus. Beyfortus, the new monoclonal antibody ...
A UPMC pulmonologist discusses RSV, including what the symptoms are, who is most at risk and how effective the vaccine is.
Respiratory syncytial virus, or RSV, is a common respiratory virus that spreads seasonally. A new drug and several vaccines that prevent the infection have recently come to market.
The Food and Drug Administration has approved giving GSK's vaccine for respiratory syncytial virus down to age 50 years old, to those who are at higher risk of severe RSV, the company said Friday ...
Two vaccines for RSV came on the market in 2023 with the goal of preventing infections and serious complications. The RSV vaccines can prevent lower respiratory tract disease (LRTD) caused by RSV.
As cases of respiratory syncytial virus (RSV) continue to rise, vaccines become harder to get due to new restrictions from health officials. The Children’s Hospital of Philadelphia sent a notice ...